A PHARMACEUTICAL COMPOSITION COMPRISNG A P2x7 - PRECEPTOR ANTAGONIST AND A TUMOUR NECOSIS FACTOR α

摘要

The invention provides a pharmaceutical product or kit comprising a first active ingredient which is a P2X7 receptor antagonist which P2X7 receptor antagonist is an adamantyl derivative and a second active ingredient which is a tumour necrosis factor α (TNFα) inhibitor, for use in the treatment of inflammatory disorders.